Olio Labs releases study showcasing AI-driven in vivo platform can predict clinical trial outcomes

San Francisco Archived • August 5, 2026 •

SOUTH SAN FRANCISCO, Calif., Aug. 5, 2026 /PRNewswire/ -- Olio Labs today published research showing that its preclinical in vivo platform predicts human clinical trial outcomes ranging from gastrointestinal adverse events to cardiac toxicity.

Source: Gillette News Record | https://www.gillettenewsrecord.com/search/?f=rss&t=article&l=50&s=start_time&sd=desc - Read Original

FB X ✉️

Discussion (0)

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!